#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Major depression

Recruiting

Investigational

Study of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:LY3537031

Contact Research Centre

COVID-19

Recruiting

Investigational

A study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:MOLNUPIRAVIR

Contact Research Centre

Cardiovascular disorder+1

Recruiting

Investigational

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:ZILEBESIRAN

Contact Research Centre

Type 2 diabetes mellitus

Recruiting

Registered drug

Efficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Semaglutide

Contact Research Centre

Irritable bowel syndrome

Recruiting

Investigational

Efficacy and Safety of Brenipatide (LY3537031) in Adults with Irritable Bowel Syndrome‑Constipation (IBS‑C) – A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:LY3537031

Contact Research Centre

Gingival bleeding+1

Recruiting

Investigational

Study on Tranexamic Acid Oral Solution for Preventing Bleeding in Patients on Blood Thinners Undergoing Tooth Extraction

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Tranexamic Acid

Contact Research Centre

Phase 2b Study of VXB-221 and VXB-213 Protein Vaccine for Prevention of Respiratory Syncytial Virus and Human Metapneumovirus Infections in Adults ≥60 Years

Not yet recruiting

Investigational

Phase 2b Study of VXB-221 and VXB-213 Protein Vaccine for Prevention of Respiratory Syncytial Virus and Human Metapneumovirus Infections in Adults ≥60 Years

Investigational

Spain

Participants:18–64 years · 65+ years · Healthy volunteers

Contact Research Centre

Arteriosclerosis

Not yet recruiting

Investigational

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Investigational

Spain

Participants:18–64 years · 65+ years

Contact Research Centre

Influenza+1

Not yet recruiting

Registered drugNo placebo

Efficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years

Registered drugNo placebo

Spain

Participants:65+ years · Healthy volunteers
Substances:INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED

Contact Research Centre

Hypercholesterolaemia

Not yet recruiting

Investigational

Study on the Effects and Safety of MK-0616 for Adults with High Cholesterol

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Mk-0616

Contact Research Centre

Respiratory syncytial virus infection

Not recruiting

Registered drugNo placebo

Study on the Safety and Immune Response of RSVPreF3 OA Vaccine with PCV20 in Adults Aged 60 and Older with RSV Disease

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate

Contact Research Centre

Respiratory syncytial virus infection+3

Not recruiting

Registered drugNo placebo

Study on the Immune Response and Safety of RSVPreF3 OA Vaccine in Adults Aged 60+ with Respiratory Syncytial Virus Infections

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.